SIRT1 and gastric cancer: In addition, it has been shown that SIRT1 plays a role in cellular proliferation, epithelial-mesenchymal transition (EMT), cell invasion, and chemoresistance in GC cells and, therefore, may be considered a potential therapeutic target [21, 22].